Cases & Deals

  • Home
  • Practices
  • Athersys receives $21 million equity investment by HEALIOS

Share

Athersys receives $21 million equity investment by HEALIOS

March 2018

Client(s) Athersys, Inc.

Jones Day represented Athersys, Inc., an international biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life, in connection with a $21 million equity investment by HEALIOS K.K., a developer of treatments for retinal diseases and age-related macular degeneration using cell technology.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.